← Back to Search

Phytochemical

Blueberry Compounds for Healthy Eating

N/A
Waitlist Available
Led By Yael Vodovotz
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be healthy, free-living adults
Be a non-smoker (defined as adults who have never smoked or who have not had a cigarette in the past ten years)
Must not have
Have been on an antibiotic regime lasting for one week in the last 6 months
Report being actively treated for any metabolic, digestive or immunologic disorder including malabsorptive disorders, renal insufficiency, hepatic insufficiency, any autoimmune disorder or short bowel syndrome
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 8 of each arm
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing how well blueberry compounds are absorbed by the body from blueberry extract and whole blueberry powder.

Who is the study for?
This trial is for healthy, non-smoking adults with a BMI of 18-35 who are not pregnant, planning to conceive, or lactating. Participants must not have any metabolic, digestive or immunologic disorders and no allergies to blueberries, wheat, or soy. They should agree to avoid berries during the study and report any accidental intake.
What is being tested?
The study is testing how well compounds called anthocyanins from blueberries are absorbed when consumed as part of two different confections: one made from blueberry extract and another from whole blueberry powder. The goal is to understand their impact on health and disease prevention.
What are the potential side effects?
Since the interventions involve consuming blueberry-based products in healthy individuals, significant side effects are not anticipated. However, potential mild side effects may include allergic reactions or gastrointestinal discomfort for those sensitive to ingredients in the confections.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a healthy adult living independently.
Select...
I have not smoked cigarettes in the past ten years.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have taken antibiotics for a week in the past 6 months.
Select...
I am currently being treated for a condition affecting my metabolism, digestion, or immune system.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 8 of each arm
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 8 of each arm for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Bioavailability of the various berry interventions

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group II (blueberry powder, blueberry extract)Experimental Treatment3 Interventions
Participants undergo a washout on days -7 to -1 and then consume blueberry powder confection on day 0. Participants undergo a second washout on days 1-7 and then consume blueberry extract confection on day 8.
Group II: Group I (blueberry extract, blueberry powder)Experimental Treatment3 Interventions
Participants undergo a washout on days -7 to -1 and then consume blueberry extract confection on day 0. Participants undergo a second washout on days 1-7 and then consume blueberry powder confection on day 8.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,917 Previous Clinical Trials
41,014,441 Total Patients Enrolled
Ohio State University Comprehensive Cancer CenterLead Sponsor
340 Previous Clinical Trials
294,243 Total Patients Enrolled
Yael VodovotzPrincipal InvestigatorOhio State University Comprehensive Cancer Center
1 Previous Clinical Trials
32 Total Patients Enrolled
~2 spots leftby Nov 2025